Myriad Genetics, Inc.
Myriad Genetics, Inc., a leading player in the precision medicine industry, is headquartered in the United States. Founded in 1991, the company has established itself as a pioneer in genetic testing and molecular diagnostics, focusing on areas such as oncology, women's health, and hereditary cancer. With a commitment to advancing healthcare through innovative solutions, Myriad offers a range of unique products and services, including genetic tests that provide critical insights for personalised treatment plans. The company has achieved significant milestones, including the development of the first FDA-approved genetic test for breast cancer risk assessment. Recognised for its contributions to the field, Myriad Genetics holds a strong market position, continually striving to enhance patient outcomes through cutting-edge technology and research.
DitchCarbon Score
How does Myriad Genetics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Myriad Genetics, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Myriad Genetics, Inc.'s reported carbon emissions
Myriad Genetics, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As of now, Myriad Genetics has not established any significant climate commitments or initiatives to reduce its carbon footprint. Without available data or targets, it is unclear how the company is addressing climate change or its environmental impact. In the context of the industry, many organisations are increasingly adopting science-based targets and sustainability initiatives to mitigate their carbon emissions. However, Myriad Genetics has yet to publicly align with such frameworks or disclose any related commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Myriad Genetics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
